Condition: Urolithiasis of Bladder · Sponsor: Thunder Bay Regional Health Research Institute
The goal of this randomized clinical trial is to determine if there is difference in pathological and clinical outcomes between MOSES and TFL in the transurethral laser enucleation of bladder tumors. The main question it aims to answer is: Is there a difference in pathological and clinical outcomes between MOSES Holmium and Thulium Fiber Laser (TFL) in the transurethral laser enucleation of bladder tumors? Participants will randomized to either TFL of MOSES arm for their bladder resection procedure.
This description comes directly from the study's public registry record.
Rabail Siddiqui · (807) 684-6000 · rabail.siddiqui@tbh.net
Shalyn Littlefield · (807) 684-6000 · shalyn.littlefield@tbh.net
Always discuss trial participation with your own doctor first.
| Thunder Bay Regional Health Sciences Centre | Thunder Bay, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06373419